Verteporfin photodynamic therapy in the UK: Implications of the NICE appraisal

Eye

Volumn 17, Issue 2, 2003, Pages 119-122

  Harding, S ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; PLACEBO;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EDITORIAL; HUMAN; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; QUALITY OF LIFE; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0037356143     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6700469     Document Type: Editorial

References (12)

1. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP Report 1. Arch Ophthalmol 1999; 117: 1329-1345.
2. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-TAP Report 2. Arch Ophthalmol 2001; 199: 198-207.
3. Verteporfin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin In Photodynamic Therapy Report 2. Am J Ophthalmol 2001; 131: 541-560.
4. Photodynamic therapy for neovascular age-related macular degeneration (Cochrane Review). 2002. The Cochrane Library, Issue 3.
5. Medical Retina Group. NICE Appraisal of Verteporfin PDT. http://www.medicalretina.org.uk. Accessed 15-11-2002.
6. National Institute for Clinical Excellence. Final Appraisal Determination: photodynamic therapy for age-related macular degeneration. http://www.nice.org.uk/article.asp?a=32774. Accessed 18-10-2002.
7. National Institute for Clinical Excellence. 2002/051 Photodynamic therapy. http://www.nice.or.uk/article.asp?a=37752. Accessed 15-11-2002.
8. Macular Photocoagulation Study Group. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol 1997; 115: 741-747.
9. National verteporfin PDT surveillance programme report. www.medicalretina.org.uk. Accessed 15-11-2002.
10. Brown GC. Vision and quality of life. Trans Am Ophthalmol Soc 1999; 97: 473-512.
11. National Institute for Clinical Excellence. HSC 1999/176: initial work programme. http://tap.ukwebhost.eds.com/doh/coin4.nsf/circulars. Accessed 18-10-2002.
12. North Essex NHS Health Authority Health Policy: Service Restriction Policy. http://www.ne-ha.nthames.nhs.uk/downloads/serv_rst.pdf. Accessed 18-10-2002.